A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma
                        AuthID
P-003-0Y3
                
    P-003-0Y3
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service